179 related articles for article (PubMed ID: 25316819)
1. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.
Ravi D; Bhalla S; Gartenhaus RB; Crombie J; Kandela I; Sharma J; Mazar A; Evens AM
Clin Cancer Res; 2014 Dec; 20(23):6023-33. PubMed ID: 25316819
[TBL] [Abstract][Full Text] [Related]
2. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
Matulis SM; Morales AA; Yehiayan L; Croutch C; Gutman D; Cai Y; Lee KP; Boise LH
Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
[TBL] [Abstract][Full Text] [Related]
3. Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.
Tian J; Zhao H; Nolley R; Reese SW; Young SR; Li X; Peehl DM; Knox SJ
Clin Cancer Res; 2012 Jun; 18(12):3366-76. PubMed ID: 22535156
[TBL] [Abstract][Full Text] [Related]
4. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
Diaz Z; Mann KK; Marcoux S; Kourelis M; Colombo M; Komarnitsky PB; Miller WH
Leukemia; 2008 Oct; 22(10):1853-63. PubMed ID: 18633430
[TBL] [Abstract][Full Text] [Related]
5. Darinaparsin: a novel organic arsenical with promising anticancer activity.
Mann KK; Wallner B; Lossos IS; Miller WH
Expert Opin Investig Drugs; 2009 Nov; 18(11):1727-34. PubMed ID: 19780704
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.
Passero FC; Ravi D; McDonald JT; Beheshti A; David KA; Evens AM
Br J Haematol; 2020 Jan; 188(2):295-308. PubMed ID: 31452195
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma.
Ravi D; Beheshti A; Abermil N; Passero F; Sharma J; Coyle M; Kritharis A; Kandela I; Hlatky L; Sitkovsky MV; Mazar A; Gartenhaus RB; Evens AM
Cancer Res; 2016 Jun; 76(11):3319-31. PubMed ID: 26988986
[TBL] [Abstract][Full Text] [Related]
8. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C
Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848
[TBL] [Abstract][Full Text] [Related]
9. Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signaling.
Bansal N; Farley NJ; Wu L; Lewis J; Youssoufian H; Bertino JR
Mol Cancer Ther; 2015 Jan; 14(1):23-30. PubMed ID: 25381261
[TBL] [Abstract][Full Text] [Related]
10. Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
Gao Y; Cai QQ; Li S; Bu Q; Liao H; Zhou Y; Huang HQ
Ai Zheng; 2009 Feb; 28(2):127-31. PubMed ID: 19550119
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological profile and clinical study results of darinaparsin (DARVIAS
Yao K; Sonehara Y; Nagahama F
Nihon Yakurigaku Zasshi; 2023; 158(5):408-418. PubMed ID: 37673618
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
Chiu HW; Ho YS; Wang YJ
J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
[TBL] [Abstract][Full Text] [Related]
13. Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation.
Locatelli SL; Careddu G; Stirparo GG; Castagna L; Santoro A; Carlo-Stella C
Sci Rep; 2016 Oct; 6():35745. PubMed ID: 27767172
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Effects of Darinaparsin, a Novel Organic Arsenical, against Human Leukemia Cells.
Yuan B; Kikuchi H; Li J; Kawabata A; Yao K; Takagi N; Okazaki M
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768603
[TBL] [Abstract][Full Text] [Related]
15. Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft.
Lee WJ; Hsiao M; Chang JL; Yang SF; Tseng TH; Cheng CW; Chow JM; Lin KH; Lin YW; Liu CC; Lee LM; Chien MH
Arch Toxicol; 2015 Jul; 89(7):1103-17. PubMed ID: 25138434
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
Sasi BK; Martines C; Xerxa E; Porro F; Kalkan H; Fazio R; Turkalj S; Bojnik E; Pyrzynska B; Stachura J; Zerrouqi A; Bobrowicz M; Winiarska M; Priebe V; Bertoni F; Mansouri L; Rosenquist R; Efremov DG
Leukemia; 2019 Oct; 33(10):2416-2428. PubMed ID: 30872780
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
